Aim Immunotech Inc. revenue decreases to $49,000 in quarter ended Mar 31, 2023 from previous quarter
Key fundamental financials- loss of $3.66 million
- Revenue of $49,000
Current Reporting | Revenue | Net Income | Profit/Loss |
---|---|---|---|
Mar 2023 | $49,000 | $3.66 million | loss |
Sep 2022 | $000 million | $0.01 million | loss |
Jun 2022 | $30,000 | $4.85 million | loss |
Candorium Free Members
Join Candorium to access the full article and more